➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Merck
Medtronic
Colorcon
Johnson and Johnson
Boehringer Ingelheim
Baxter

Last Updated: August 12, 2020

DrugPatentWatch Database Preview

LITHIUM CARBONATE - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for lithium carbonate and what is the scope of freedom to operate?

Lithium carbonate is the generic ingredient in seven branded drugs marketed by Noven Therap, Able, Alembic Ltd, Apotex Inc, Glenmark Generics, Hetero Labs Ltd Iii, Hikma, Mylan, Usl Pharma, Watson Labs, Solvay, Jds Pharms, Alembic Pharms Ltd, Glenmark Pharms Inc, Heritage Pharma, Hikma Intl Pharms, Mylan Pharms Inc, Unique Pharm Labs, Ani Pharms Inc, Bayer Pharms, Pfizer, and Sun Pharm Inds Inc, and is included in thirty-six NDAs. Additional information is available in the individual branded drug profile pages.

There are fifteen drug master file entries for lithium carbonate. Twenty-three suppliers are listed for this compound.

Drug Prices for LITHIUM CARBONATE

See drug prices for LITHIUM CARBONATE

Drug Sales Revenue Trends for LITHIUM CARBONATE

See drug sales revenues for LITHIUM CARBONATE

Recent Clinical Trials for LITHIUM CARBONATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
All India Institute of Medical Sciences, BhubaneswarPhase 4
Amarex Clinical ResearchPhase 2
StemCyte, Inc.Phase 2

See all LITHIUM CARBONATE clinical trials

Pharmacology for LITHIUM CARBONATE
Drug ClassMood Stabilizer
Medical Subject Heading (MeSH) Categories for LITHIUM CARBONATE

US Patents and Regulatory Information for LITHIUM CARBONATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Usl Pharma LITHIUM CARBONATE lithium carbonate CAPSULE;ORAL 072542-001 Feb 1, 1989 DISCN No No   Start Trial   Start Trial   Start Trial
Pfizer LITHIUM CARBONATE lithium carbonate TABLET;ORAL 016834-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Hikma LITHIUM CARBONATE lithium carbonate CAPSULE;ORAL 017812-001 Approved Prior to Jan 1, 1982 AB RX Yes No   Start Trial   Start Trial   Start Trial
Alembic Ltd LITHIUM CARBONATE lithium carbonate CAPSULE;ORAL 079159-001 Jan 12, 2009 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Johnson and Johnson
Harvard Business School
McKesson
Boehringer Ingelheim
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.